Episynesis Limited
Research and experimental development on biotechnology
Episynesis Limited contacts: address, phone, fax, email, website, shedule
Address: 42 Apthorpe Street Fulbourn CB21 5EY Cambridge
Phone: +44-1300 3518341
Fax: +44-1300 3518341
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Episynesis Limited"? - send email to us!
Registration data Episynesis Limited
Register date: 2013-04-22
Register number: 08497829
Type of company: Private Limited Company
Get full report form global database UK for Episynesis LimitedOwner, director, manager of Episynesis Limited
Robert Michael Roland Arnold Director. Address: Apthorpe Street, Fulbourn, Cambridge, CB21 5EY, United Kingdom. DoB: October 1950, British
Dr Frank Hallock Ebetino Director. Address: Apthorpe Street, Fulbourn, Cambridge, CB21 5EY, United Kingdom. DoB: April 1956, Usa
Jobs in Episynesis Limited vacancies. Career and practice on Episynesis Limited. Working and traineeship
Cleaner. From GBP 1100
Director. From GBP 6600
Carpenter. From GBP 2100
Project Planner. From GBP 2700
Driver. From GBP 2300
Electrical Supervisor. From GBP 1900
Tester. From GBP 3000
Driver. From GBP 2200
Responds for Episynesis Limited on FaceBook
Read more comments for Episynesis Limited. Leave a respond Episynesis Limited in social networks. Episynesis Limited on Facebook and Google+, LinkedIn, MySpaceAddress Episynesis Limited on google map
Other similar UK companies as Episynesis Limited: Bexley Apartments Limited | Wardquote Limited | Parklands (bucknall) Management Company Limited | The Point Lincolnfields Management Company Limited | Direct Approach Marketing Limited
This company is widely known under the name of Episynesis Limited. This company was started 3 years ago and was registered under 08497829 as its company registration number. This head office of the company is based in Cambridge. You can contact it at 42 Apthorpe Street, Fulbourn. This company SIC code is 72110 and has the NACE code: Research and experimental development on biotechnology. The company's most recent filings were filed up to 2016-04-30 and the latest annual return information was filed on 2016-04-22. Right from the start three years ago, the company has been a reference point for others on this market, achieving spectacular success.
In order to be able to match the demands of its clientele, the company is consistently supervised by a team of two directors who are Robert Michael Roland Arnold and Dr Frank Hallock Ebetino. Their mutual commitment has been of utmost importance to this specific company since 2013.
